Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs)-an enzyme family that deacetylates histones and non-histone proteins-are implicated in human diseases such as cancer, and the first-generation of HDAC inhibitors are now in clinical trials. Here, we report the 2.0 A resolution crystal structure of a catalytically inactive HDAC8 active-site mutant, Tyr306Phe, bound to an acetylated peptidic substrate. The structure clarifies the role of active-site residues in the deacetylation reaction and substrate recognition. Notably, the structure shows the unexpected role of a conserved residue at the active-site rim, Asp 101, in positioning the substrate by directly interacting with the peptidic backbone and imposing a constrained cis-conformation. A similar interaction is observed in a new hydroxamate inhibitor-HDAC8 structure that we also solved. The crucial role of Asp 101 in substrate and inhibitor recognition was confirmed by activity and binding assays of wild-type HDAC8 and Asp101Ala, Tyr306Phe and Asp101Ala/Tyr306Phe mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, D94 corresponds to acetyllysine binding residues D101 of hHDAC8 and S568 of hHDAC6 CD2 (refs 17, 30, 31).”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In HDAC8, highly conserved D101 accepts hydrogen bonds from the two backbone amide groups flanking the scissile acetyllysine residue.37,38”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [37]
In the citing paper
“Crystal structures of human HDAC8, in complex with different inhibitors, have been reported; they revealed a single α/β-domain with a core eight-stranded parallel β-sheet and 11 α-helices.7, 31, 32”
From HDAC8 catalyzes the hydrolysis of long chain fatty acyl lysine (2016) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742 · cited 1×
“Model building was carried out using QUANTA2000 (Accelrys, Cambridge, UK) and refinement with REFMAC (Murshudov et al, 1997).”
MethodPRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845 · cited 1×
“Acetylation status of the lysine residue at the N-terminal extensions of core histones is controlled by two counteracting enzymes: histone acetyl transferases and histone deacetylases (HDACs; Roth et al, 2001; Marks et al, 2003).”
BackgroundStructures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · cited 6×
“The HDAC8 active site (Somoza et al, 2004; Vannini et al, 2004) presents features of both serine and zinc proteases, and contains two His–Asp dyads with both histidine residues supposed to work as a general acid–base catalytic pair, as originally proposed for HDLP and extended to HDAH (Finnin et al, 1999; Nielsen et a…”
BackgroundResultInfluentialThe Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495 · cited 1×
“HDAC11 is distinct from those in classes I and II; therefore, it has been placed in class IV, as class III refers to the unrelated sirtuin deacetylases (Blander & Guarente, 2004).”
BackgroundGregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456 · cited 1×
“Eukaryotic HDACs have been classified into four groups on the basis of phylogenetic analysis (Gregoretti et al, 2004).”
Backgroundp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · cited 2×
“whereas the substrate has no coumarin group, substituted instead with Leu-Met and corresponding to p53 protein sequence 379–384 (Liu et al, 1999).”
BackgroundFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“The only significant exception is Tyr306, which is histidine in class IIa HDACs (4, 5, 7, 9), which causes a pronounced decrease in catalytic activity on peptidic substrates (Fischle et al, 2002).”
BackgroundStructural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678 · cited 1×
“As these processes are modulated during malignant transformation, HDAC inhibitors are being developed as antineoplastic drugs (Gallinari et al, 2007), and vorinostat was recently approved by the Food and Drug Administration for the treatment of cutaneous T-cell lymphoma.”
BackgroundSelf-citationVannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
Self-citationImplementation of molecular replacement in AMoRe
Navaza, J. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901012422 · Cited by 613 · cited 1×
“Both structures were solved by molecular replacement with AMoRe (Navaza, 2001), using the Protein Data Bank entry 1w22 as a search model (Vannini et al, 2004).”
MethodA role for histone deacetylase activity in HDAC1-mediated transcriptional repression
Hassig, C. A., Tong, J. K., Fleischer, T. C., Owa, T., Grable, P. G., Ayer, D. E., & Schreiber, S. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3519 · Cited by 365 · cited 1×
“…at His142 but not at His143 (Vanommeslaeghe et al, 2005) and the finding that His143 mutation in HDAC1 reduced but did not abolish activity (Hassig et al, 1998) indicate a possible role of His143 in orientating the substrate rather than a role in protonating the amine-leaving group…”
BackgroundRegulation of histone deacetylase activities
Sengupta, N., & Seto, E. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20179 · Cited by 346 · cited 1×
“With the exception of HDAC8, functional HDACs are not found as single polypeptides, but as high-molecular-weight multiprotein complexes (Yang & Seto, 2003), and most purified recombinant HDACs are enzymatically inactive (Sengupta & Seto, 2004).”
BackgroundMarks, P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00084-5 · Cited by 344
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression
Yang, X.-J., & Seto, E. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00015-7 · Cited by 241 · cited 1×
“With the exception of HDAC8, functional HDACs are not found as single polypeptides, but as high-molecular-weight multiprotein complexes (Yang & Seto, 2003), and most purified recombinant HDACs are enzymatically inactive (Sengupta & Seto, 2004).”
BackgroundCrystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 158 · cited 6×
“The HDAC8 active site (Somoza et al, 2004; Vannini et al, 2004) presents features of both serine and zinc proteases, and contains two His–Asp dyads with both histidine residues supposed to work as a general acid–base catalytic pair, as originally proposed for HDLP and extended to HDAH (Finnin et al, 1999; Nielsen et a…”
BackgroundResultInfluentialStructure and activity of enzymes that remove histone modifications
Holbert, M. A., & Marmorstein, R. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.006 · Cited by 127 · cited 1×
“However, they all have homologous catalytic sites and are considered to go through a similar reaction mechanism (Holbert & Marmorstein, 2005).”
BackgroundAcetylation of proteins as novel target for antitumor therapy: Review article
Gennaro, E. D., Bruzzese, F., Caraglia, M., Abruzzese, A., & Budillon, A. (2004) · Amino Acids · doi:10.1007/s00726-004-0087-3 · Cited by 94 · cited 1×
“However, HDACs also participate in the regulation of non-histone proteins and are therefore important in many biological processes such as cell-cycle progression, cell survival and differentiation (Di Gennaro et al, 2004).”
BackgroundA series of novel, potent, and selective histone deacetylase inhibitors
JONES, P. G., Altamura, S., Chakravarty, P. K., Cecchetti, O., Francesco, R. D., Gallinari, P., Ingenito, R., Meinke, P. T., Petrocchi, A., Rowley, M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.002 · Cited by 68
Self-citationRodriquez, M., Aquino, M., Bruno, I., Martino, G., Taddei, M., & Gomez-Paloma, L. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360905 · Cited by 64 · cited 1×
“…several of the most potent HDAC inhibitors— despite the large diversity in the cap moiety—have two amides as part of the cap ( Jones et al, 2006; Rodriquez et al, 2006), and are therefore likely to establish such interactions with Asp101 in HDAC8 or corresponding aspartic acid residues in…”
BackgroundPhosphorus-Based SAHA Analogues as Histone Deacetylase Inhibitors
Kapustin, G. V., Fejér, G., Gronlund, J. L., McCafferty, D. G., Seto, E., & Etzkorn, F. A. (2003) · Organic Letters · doi:10.1021/ol035056n · Cited by 56 · cited 2×
“…et al, 1999; Somoza et al, 2004; Vannini et al, 2004; Nielsen et al, 2005), and excludes the role of residue 306 as a water-activated nucleophile (Kapustin et al, 2003; Vanommeslaeghe et al, 2003) because the active-site water molecule is far away from residue 306 and is on the opposite side…”
BackgroundInfluentialLaskowski, R. A. (2003) · Methods of biochemical analysis · doi:10.1002/0471721204.ch14 · Cited by 54 · cited 1×
“Both models show good stereochemistry, as assessed by PROCHECK (Laskowski, 2003), with 91% of total residues in the most favoured regions and 9% in additionally allowed regions of the Ramachandran plot, for structure A (90.5 and 9.5%, for structure B, respectively).”
MethodInfluentialVanommeslaeghe, K., Proft, F. D., Loverix, S., Tourwé, D. A., & Geerlings, P. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.001 · Cited by 46 · cited 8×
“Instead, the non-conservation of the exposed charge–relay system (His143/Asp183, Asn or Gln; supplementary Fig S3 online), the suggestion of recent theoretical studies of HDAC protonated at His142 but not at His143 (Vanommeslaeghe et al, 2005) and the finding that His143 mutation in HDAC1 reduced but did not abolish a…”
BackgroundInfluentialHDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Paola, Gallinari, Di, Marco, M. D., Phillip, Jones, Michèle, Pallaoro, Christian, C., & Steinkühler (2007) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 35
Vanommeslaeghe, K., Alsenoy, C. V., Proft, F. D., Martins, J. C., Tourwé, D., & Geerlings, P. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b304707e · Cited by 31 · cited 1×
“…et al, 2004; Vannini et al, 2004; Nielsen et al, 2005), and excludes the role of residue 306 as a water-activated nucleophile (Kapustin et al, 2003; Vanommeslaeghe et al, 2003) because the active-site water molecule is far away from residue 306 and is on the opposite side with respect to the…”
BackgroundVaghefi, H., & Neet, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207953 · Cited by 27 · cited 2×
“Lys382 deacetylation by class I HDACs results in repression of the transcriptional activity of p53 (Vaghefi & Neet, 2004).”
Background
Cited by
NCIPLOT: A Program for Plotting Noncovalent Interaction Regions
Contreras-García, J., Johnson, E. R., Keinan, S., Chaudret, R., Piquemal, J.-P., Beratan, D. N., & Yang, W. (2011) · Journal of Chemical Theory and Computation · doi:10.1021/ct100641a · Cited by 4,076
Class I histone deacetylases (HDAC1–3) are histone lysine delactylases
Moreno-Yruela, C., Zhang, D., Wei, W., Bæk, M., Liu, W., Gao, J., Danková, D., Nielsen, A. L., Bolding, J. E., Yang, L., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi6696 · Cited by 841
“For example, SIRT5 is an efficient lysine demalonylase, desuccinylase, and deglutarylase but not deacetylase (25–28), and HDAC8, HDAC11, SIRT2, and SIRT6 harbor substantial activities against long chain acyl modifications (29–33).”
BackgroundInfluentialHDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition
Hai, Y., & Christianson, D. W. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2134 · Cited by 521
“37,38 However, the corresponding residue in zCD2, N530, was offset such that S531 of zCD2 structurally aligned with D101 of HDAC8 and accepted a hydrogen bond from the backbone NH group of acetyllysine in substrates 1 and 8 (Fig.”
Chemical mechanisms of histone lysine and arginine modifications
Smith, B. C., & Denu, J. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.005 · Cited by 390
“In the first chemical step, both His-142 [83–85,88] and His-143 [87] have been implicated as the general base that activates the water molecule for nucleophilic attack of the acetyl carbonyl carbon.”
BackgroundInfluential
Metadata
- Authors
- Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S.
- Affiliations
- Institute of Molecular Biology and Pathology (IT)
- Venue
- The EMBO Reports
- Published
- 2007-08-10
- Volume
- 8
- Issue
- 9
- Pages
- 879-884
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1973954
- OpenAlex
- W2164806419
- Cited by
- 256
- References
- 27
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 13 · 2019: 16 · 2018: 14 · 2017: 18 · 2016: 21 · 2015: 14 · 2014: 16 · 2013: 16 · 2012: 17
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- HDAC8, substrate binding, active site residues, hydroxamate inhibitors, substrate recognition, catalytically inactive mutant, histone deacetylase inhibitors
- MeSH terms
- Aspartic Acid, Enzyme Inhibitors, Histone Deacetylases, Humans, Models, Molecular, Repressor Proteins, Structure-Activity Relationship, Substrate Specificity, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.